presentation by Josep M Guiu, Head of pharmaceutical planning and pharmacotherapy coordination at the Catalan Health and Social Care Consortium in Barcelona, Spain, at 3D Pharma Printing Conference, 4 February 2021, 12:00 – 16:00 CET. REGISTER HERE to attend.
There is a huge potential of 3D printing to revolutionise clinical pharmacy practice with the development of a new generation of personalized compounded drugs. The implementation of a 3D printer into a hospital pharmacy could make possible to individualize shapes, sizes and dosages of several oral drugs to patients.
However, its implementation needs the collaboration of hospital pharmacists with pharmaceutical scientists and the pharmaceutical industry, as well as to define a new regulatory framework for these new drugs.
What drives you?
Being a hospital pharmacist means you’re part of a team where the focus is firmly on patients. Using my knowledge about medicines to improve the health of patients is highly rewarding.
Why should the delegate attend your presentation?
Healthcare professionals should be optimistic, but also critical about the introduction of new technologies into clinical practice. In this session I will discuss the main barriers and difficulties for 3D printing of drugs for the hospital pharmacy.
What emerging technologies/trends do you see as having the greatest potential in the short and long run?
It is time to advance in personalized medicine. But this is not limited to gene and cell therapies, which are already here and their cilnical potential has only just begun. Individualizing treatments also means using new drug-making technologies, such as 3D printing.
What kind of impact do you expect them to have?
The new drugs will not only improve the effectiveness of future treatments. In some cases, they will completely change the way health professionals work and how we treat patients.
What are the barriers that might stand in the way?
Sustainability is one of the main challenges that health systems are facing. The innovation of the future must be a factor that promotes sustainability.
Hospital pharmacists are key professionals in the assessment and selection of medicines, and they will also be the professionals who will lead the incorporation of 3D printed drugs into clinical practice.
Dr. Josep M Guiu received his licensure in Pharmacy from the University of Barcelona. He completed his hospital pharmacy training at Vall d’Hebron University Hospital in Barcelona and obtained his hospital pharmacy specialty from the Ministry of Health of Spain. He is also adjunct lecturer of clinical pharmacy at the Faculty of Pharmacy and Food Sciences of the University of Barcelona and he is the Secretary of the Catalan Society of Clinical Pharmacy. Since 2018, is Vice president for the Euro region of the Hospital Pharmacy Section Executive Committee of the International Pharmaceutical Federation (FIP).